Drawing for CLINIHUB

USPTO serial 88360620

CLINIHUB

Reviewed by CopyMark Law Group

Reg. 6050842Status 700Registered
Filing date
Status date
Registration date
May 12, 2020
Examiner
GADSON, SHARI B.
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CLINIHUB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maren C. Perry

Maren C. Perry King & Spalding LLP1185 Avenue of the AmericasNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
009Magnetic, electronic and optical data carriers containing information relating to medicine; downloadable software for scientific research and design related clinical trials in the field of central nervous system diseases and disorders; downloadable computer application software for the design and implementation of clinical studies in the field of medicine; downloadable mobile application software for clinical study data and design; data processing smart watches and wearable activity trackers; downloadable images in the field of central nervous system diseases and disorders for use on mobile phones; electronic information management systems in the medical sector composed primarily of downloadable software for database management of clinical trial information; recorded computer software, namely, software for organizing and tracking medical and pharmaceutical information, education and sales activities; downloadable software for creating and managing websites, intranet and internet; data processing equipment and computers; downloadable application software for database management in the field of clinical trials and mobile devices and applications for information and interaction; downloadable application software for social networking via the internet; downloadable software in the nature of a mobile application for providing information on health, healthcare and medicine; downloadable software in the nature of a mobile application for facilitating communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical, and health fieldsACTIVE—
042Pharmaceutical research and development; scientific and technological services, namely, scientific research and design related to the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and medical testing services in the field of central nervous system research; clinical medical research and medical testing services in the field of central nervous system research; diagnostic medical research; providing on-line non-downloadable software tools for assessment of cognitive functions; providing online non-downloadable, software tools for diagnosing, managing, monitoring, assessing, measuring, controlling and examining psychiatric and neurological disorders and diseasesACTIVE—
044Medical, clinical medical practice consultation, therapeutic radiological services and healthcare services; medical, clinical, therapeutic and healthcare information services; services in the field of psychiatry, psychology and neurology; health screening services in the field of central nervous system diseases and disorders; advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, information regarding medical dose, diagnosis, therapeutic issues and medical management; medical testing services for diagnostic or treatment purposes; medical diagnostic and clinical testingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 12, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 22, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 22, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Mar 22, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 12, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 22, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 13, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 13, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 13, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 13, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 13, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 13, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 13, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2019ALIEASSIGNED TO LIE—
Dec 6, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2019DOCKASSIGNED TO EXAMINER—
Apr 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance